SEC 13F Intelligence

Monarch Capital Management Inc / ABT

Monarch Capital Management Inc’s Abbott Laboratories Position

Does Monarch Capital Management Inc own Abbott Laboratories (ABT)? Yes — 54.3K shares worth $6M (+1.36% of its 13F portfolio) as of Q1 2026, down from 54.3K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
54.3K
% of Portfolio
+1.36%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $7MQ2 ’19: $7MQ3 ’19: $7MQ4 ’19: $7MQ4 ’19Q1 ’20: $6MQ2 ’20: $7MQ3 ’20: $8MQ4 ’20: $8MQ4 ’20Q1 ’21: $8MQ2 ’21: $8MQ3 ’21: $8MQ4 ’21: $9MQ4 ’21Q1 ’22: $8MQ2 ’22: $7MQ3 ’22: $6MQ4 ’22: $7MQ4 ’22Q1 ’23: $6MQ2 ’23: $6MQ3 ’23: $6MQ4 ’23: $6MQ4 ’23Q1 ’24: $6MQ2 ’24: $6MQ3 ’24: $6MQ4 ’24: $6MQ4 ’24Q1 ’25: $7MQ2 ’25: $7MQ3 ’25: $7MQ4 ’25: $7MQ4 ’25Q1 ’26: $6Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202654.3K$6M+1.36%
Q4 202554.3K$7M+1.67%
Q3 202554.5K$7M+1.79%
Q2 202553.7K$7M+1.96%
Q1 202554.7K$7M+2.02%
Q4 202456.2K$6M+1.74%
Q3 202456.2K$6M+1.72%
Q2 202455.4K$6M+1.69%
Q1 202456.1K$6M+1.80%
Q4 202356.4K$6M+1.88%
Q3 202357.9K$6M+1.80%
Q2 202357.9K$6M+1.91%
Q1 202358.3K$6M+1.81%
Q4 202259.8K$7M+2.01%
Q3 202262.1K$6M+1.96%
Q2 202264.6K$7M+2.09%
Q1 202264.5K$8M+2.02%
Q4 202165.0K$9M+2.35%
Q3 202166.9K$8M+2.20%
Q2 202166.5K$8M+2.20%
Q1 202166.0K$8M+2.34%
Q4 202069.8K$8M+2.40%
Q3 202071.6K$8M+2.71%
Q2 202073.1K$7M+2.44%
Q1 202076.2K$6M+2.45%
Q4 201979.2K$7M+2.24%
Q3 201981.9K$7M+2.39%
Q2 201983.2K$7M+2.50%
Q1 201983.9K$7M+2.43%
Q4 201886.0K$6M+2.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Monarch Capital Management Inc’s full portfolio or all institutional holders of ABT.